Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Pinitpatcharalert, A."'
Autor:
Zelefsky, Michael J., Pinitpatcharalert, Attapol, Kollmeier, Marisa, Goldman, Debra A., McBride, Sean, Gorovets, Daniel, Zhang, Zhigang, Varghese, Melissa, Happersett, Laura, Tyagi, Neelam, Hunt, Margie
Publikováno v:
In European Urology Oncology December 2020 3(6):748-755
Autor:
Imjai Chitapanarux, Pitchayaponne Klunklin, Attapol Pinitpatcharalert, Patumrat Sripan, Ekkasit Tharavichitkul, Wannapha Nobnop, Wimrak Onchan, Somvilai Chakrabandhu, Bongkot Jia-Mahasap, Juntima Euathrongchit, Yutthaphan Wannasopha, Tanop Srisuwan
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Objective We evaluated the long-term outcomes and late toxicity of conventional fractionated (CF) and hypofractionated (HF) postmastectomy radiotherapy (PMRT) in terms of locoregional recurrence-free survival (LRRFS), disease-free survival (
Externí odkaz:
https://doaj.org/article/782b93ecb1b54df09d42acb0e1600cc6
Autor:
Attapol Pinitpatcharalert, MD, Laura Happersett, MS, Marisa Kollmeier, MD, Sean McBride, MD, Daniel Gorovets, MD, Neelam Tyagi, PhD, Melissa Varghese, BA, Michael J. Zelefsky, MD
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 2, Pp 337-344 (2019)
Purpose: This study aimed to evaluate the toxicity of prostate and pelvic lymph node stereotactic body radiation therapy (SBRT) for high-risk prostate cancer. Methods and Materials: Twenty-three patients with high-risk or lymph node-positive prostate
Externí odkaz:
https://doaj.org/article/7d3573600b8842eeba10795df69192df
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Laura Happersett, Neelam Tyagi, Michael J. Zelefsky, Achiraya Teyateeti, Attapol Pinitpatcharalert, Daniel Gorovets, Margaret Hopkins, Sean McBride, Zhigang Zhang, Behfar Ehdaie, Victor E. Reuter, Marisa A. Kollmeier, Debra A. Goldman, Samson W. Fine
Publikováno v:
Radiother Oncol
PURPOSE: To investigate predictors associated with post-treatment biopsy outcomes after stereotactic body radiotherapy (SBRT) for localized prostate cancer. MATERIALS AND METHODS: 257 patients treated with prostate SBRT to dose levels of 32.5 Gy to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422e9d7186484c768db9fca9036618c1
https://doi.org/10.1016/j.radonc.2021.02.008
https://doi.org/10.1016/j.radonc.2021.02.008
Autor:
Nutthapong Moonkum, Suriyaporn Turathong, Attapol Pinitpatcharalert, Janrudi Seechompoo, Chantiya Suetong, Nuttapong Danthanavat, Gunjanaporn Tochaikul
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 192
The purpose of this study was to perform in-vivo dosimetry using a diode rectal dosimeter in phantom and compare the dose delivered to the rectum between the dose measured by the diode dosimeter and the dose calculated by the treatment planning syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbc490b5eb4392cb9f54bd8b18988a3a
https://pubmed.ncbi.nlm.nih.gov/36495786
https://pubmed.ncbi.nlm.nih.gov/36495786
Autor:
Michael J. Zelefsky, Attapol Pinitpatcharalert, Sean McBride, Laura Happersett, Neelam Tyagi, Marisa A. Kollmeier, Daniel Gorovets, Debra A. Goldman, Melissa Varghese, Margie Hunt, Zhigang Zhang
Publikováno v:
Eur Urol Oncol
BACKGROUND: Studies using stereotactic body radiotherapy (SBRT) dose escalation in in low- and intermediate-risk prostate cancer patients have indicated favorable outcomes. OBJECTIVE: To evaluate tolerance and tumor control outcomes in low- and inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d69d02c604bc82e641bbdceca16aaca
https://doi.org/10.1016/j.euo.2019.09.006
https://doi.org/10.1016/j.euo.2019.09.006
Autor:
Daniel Gorovets, Michael J. Zelefsky, Attapol Pinitpatcharalert, Neelam Tyagi, Melissa Varghese, Laura Happersett, Marisa A. Kollmeier, Sean McBride
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 2, Pp 337-344 (2019)
Advances in Radiation Oncology
Advances in Radiation Oncology
Purpose This study aimed to evaluate the toxicity of prostate and pelvic lymph node stereotactic body radiation therapy (SBRT) for high-risk prostate cancer. Methods and Materials Twenty-three patients with high-risk or lymph node-positive prostate c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1b7a325a41fc00cd9f8a696f19f61c7
http://www.sciencedirect.com/science/article/pii/S2452109418302434
http://www.sciencedirect.com/science/article/pii/S2452109418302434
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wannapha Nobnop, Tanop Srisuwan, Somvilai Chakrabandhu, Bongkot Jia-Mahasap, Juntima Euathrongchit, Wimrak Onchan, Imjai Chitapanarux, Attapol Pinitpatcharalert, Pitchayaponne Klunklin, Patumrat Sripan, Ekkasit Tharavichitkul, Yutthaphan Wannasopha
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
ObjectiveWe evaluated the long-term outcomes and late toxicity of conventional fractionated (CF) and hypofractionated (HF) postmastectomy radiotherapy (PMRT) in terms of locoregional recurrence-free survival (LRRFS), disease-free survival (DFS), over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4974aa41c0022136a7a2b2b458b4ad
https://doi.org/10.1186/s13014-019-1378-x
https://doi.org/10.1186/s13014-019-1378-x